Progressive Reports March 2024 Results
MAYFIELD VILLAGE, OHIO, April 12, 2024 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the […]
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
WESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted […]
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
In a preliminary review of blinded data from the ongoing TREK-DX study, 45% (10/22) of patients achieved at least a […]
Notable Labs Reports 2023 Financial Results and Provides a Business Update
FOSTER CITY, Calif., April 12, 2024 (GLOBE NEWSWIRE) — Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable” or the “Company”), a clinical-stage […]
Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual Meeting
NOVATO, Calif., April 12, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that preclinical and clinical data, […]
JOYY Inc. Announces Repurchase Right Notification for 1.375% Convertible Senior Notes due 2026
SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) — JOYY Inc. (Nasdaq: YY) (“JOYY” or the “Company”), a global technology company, today […]
Syntec Optics (Nasdaq: OPTX) Secures Order to Develop New Disposable Optics for Digital Health Treatment
ROCHESTER, NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) — Syntec Optics, a leading provider of mission-critical optics for scientific and […]
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
BOSTON, April 12, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
BOSTON, April 12, 2024 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based […]
Aeries Technology, Inc. Announces $5 Million PIPE
NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (“Aeries” or “the Company”) (Nasdaq: AERT), a global professional […]
